Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
4.030
-0.610 (-13.15%)
Jun 5, 2026, 4:00 PM EDT - Market closed
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $287.75 million as of June 5, 2026. Its market cap has increased by 385.22% in one year.
Market Cap
287.75M
Enterprise Value
228.99M
1-Year Change
385.22%
Ranking
Category
Stock Price
$4.03
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $287.75M, an increase of 1,253.33%. That is a compound annual growth rate of 59.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 4, 2026 | 331.31M | 139.01% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rocket Pharmaceuticals | 325.40M |
| Fennec Pharmaceuticals | 324.44M |
| Neumora Therapeutics | 323.36M |
| Lineage Cell Therapeutics | 309.13M |
| DiaMedica Therapeutics | 308.75M |
| Silence Therapeutics | 301.83M |
| Lyell Immunopharma | 300.08M |
| InflaRx | 299.00M |